Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
| Autor: | Alberto A. Amarilla, David A. Muller, Naphak Modhiran, Nigel A.J. McMillan, Aroon Supramaniam, Ariel Isaacs, Jovin J Y Choo, Helle Bielefeldt-Ohmann, Christopher L. D. McMillan, Adi Idris, Gabrielle E. Kelly, Michael J. Landsberg, Germain J. P. Fernando, Stacey T. M. Cheung, Daniel Watterson, Benjamin Liang, Armira Azuar, Paul R. Young, Alexander A. Khromykh, Dhruba Acharya |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Science Advances |
| ISSN: | 2375-2548 |
| DOI: | 10.1126/sciadv.abj8065 |
| Popis: | Description Delivery of a SARS-CoV-2 vaccine to the skin of mice via microarray patches provides complete protection from challenge. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 160 million people and resulted in more than 3.3 million deaths, and despite the availability of multiple vaccines, the world still faces many challenges with their rollout. Here, we use the high-density microarray patch (HD-MAP) to deliver a SARS-CoV-2 spike subunit vaccine directly to the skin. We show that the vaccine is thermostable on the patches, with patch delivery enhancing both cellular and antibody immune responses. Elicited antibodies potently neutralize clinically relevant isolates including the Alpha and Beta variants. Last, a single dose of HD-MAP–delivered spike provided complete protection from a lethal virus challenge in an ACE2-transgenic mouse model. Collectively, these data show that HD-MAP delivery of a SARS-CoV-2 vaccine was superior to traditional needle-and-syringe vaccination and may be a significant addition to the ongoing COVID-19 (coronavirus disease 2019) pandemic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|